Combining multiple meds into a single pill reduces cardiovascular deaths

Combining multiple meds into a single pill reduces cardiovascular deaths

New research at the School of Medicine bolsters previous findings that “polypills” — single pills that combine medications that target cardiovascular disease-related conditions — are beneficial in preventing heart attacks and strokes and reducing deaths. As a result of the study, the World Health Organization has added such polypills to its most recent Model List of Essential Medicines.
Some sarcoma patients improve with T cell immunotherapy

Some sarcoma patients improve with T cell immunotherapy

A clinical trial led by School of Medicine researchers has shown that a T cell immunotherapy — in which the patients’ own T cells are genetically modified to attack and kill cancer cells — is effective in treating some patients with rare cancers of the body’s soft tissues. The study focused on the rare cancers synovial sarcoma and myxoid round cell liposarcoma.
Huebsch wins NSF CAREER award

Huebsch wins NSF CAREER award

The National Science Foundation has given a CAREER award to Nathaniel Huebsch, an assistant professor of biomedical engineering in the McKelvey School of Engineering at Washington University in St. Louis.
DiPersio honored with E. Donnall Thomas lectureship

DiPersio honored with E. Donnall Thomas lectureship

John F. DiPersio, MD, PhD, the Virginia E. and Sam J. Golman Professor of Medicine at the School of Medicine, delivered the E. Donnall Thomas Lecture in San Antonio at the Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research.
Older Stories